South and Central America
Diabetes regional report 2000 — 2050
Skip Map
Download Factsheet
Number of adults (20–79 years) with diabetes in South and Central America (SACA)
| 2000 | 8.6 million |
| 2011 | 25.1 million |
| 2024 | 35.4 million |
| 2050 | 51.5 million |
Estimates were included for 19 countries and territories in the IDF South and Central America (SACA) Region. The estimates for diabetes prevalence in adults aged 20–79 years were based on 29 data sources from 15 countries. Fourcountries: Brazil, Peru, Panama and Bolivia had studies conducted within the past five years.
IDF projects that the number of people with diabetes in the SACA Region will increase by 46%, reaching 52 million by 2050. Over the same period, the prevalence of diabetes will increase by 23%, reaching 12.3%. In 2024, 81 billion USD was spent on diabetes in the Region, representing 8% of total expenditure worldwide.
2000
2011
2024
2050
Loading...
| Diabetes estimates (20-79 y) | ||||
|---|---|---|---|---|
| People with diabetes, in 1,000s | 8,553.3 | 25,121.5 | 35,366.9 | 51,499.8 |
| Age-standardised prevalence of diabetes, % | 3.7 | 9.2 | 10.1 | 11.5 |
| Proportion of people with undiagnosed diabetes, % | - | - | 30.4 | - |
| People with undiagnosed diabetes, in 1,000s | - | - | 10,737.5 | - |
| Impaired Fasting Glucose (IFG) | ||||
|---|---|---|---|---|
| People with IFG, in 1,000s | - | - | 32,238.6 | 43,187.2 |
| Age-standardised prevalence of IFG, % | - | - | 9.2 | 10.0 |
| Impaired Glucose Tolerance (IGT) | ||||
|---|---|---|---|---|
| People with IGT, in 1,000s | - | 15,100.0 | 38,678.4 | 51,909.9 |
| Age-standardised prevalence of IGT, % | - | 5.4 | 11.0 | 11.9 |
| Mortality attributable to diabetes (20-79 y) | ||||
|---|---|---|---|---|
| Deaths attributable to diabetes | - | 227,200.0 | 223,539.6 | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - | - | 10.4 | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | ||||
|---|---|---|---|---|
| Live births affected by HIP | - | - | 967,187.0 | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - | - | 12.5 | - |
| Live births affected by other types of diabetes first detected in pregnancy | - | - | 66,798.7 | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - | - | 143,511.1 | - |
| Diabetes-related health expenditure | ||||
|---|---|---|---|---|
| Total diabetes-related health expenditure, USD million | - | 20,800.0 | 80,840.1 | 94,512.8 |
| Total diabetes-related health expenditure, ID million | - | - | 150,434.1 | 175,774.2 |
| Diabetes-related health expenditure per person, USD | - | 932.8 | 2,417.4 | 1,937.5 |
| Diabetes-related health expenditure per person, ID | - | - | 4,498.6 | 3,603.3 |
| Type 1 diabetes estimates in children and adolescents | ||||
|---|---|---|---|---|
| People with type 1 diabetes (all age groups) | - | - | 797,112.0 | - |
| People with type 1 diabetes (0-19 y) | - | - | 162,586.0 | - |
| Demographics | ||||
|---|---|---|---|---|
| Total adult population (20-79 y), in 1,000s | 233,013.0 | 289,000.0 | 354,582.6 | 419,502.2 |
| Population of children and adolescents (0-19 y) | - | - | 151,278,086.5 | - |
Loading...
| Diabetes estimates (20-79 y) | |
|---|---|
| People with diabetes, in 1,000s | 8,553.3 |
| Age-standardised prevalence of diabetes, % | 3.7 |
| Proportion of people with undiagnosed diabetes, % | - |
| People with undiagnosed diabetes, in 1,000s | - |
| Impaired Fasting Glucose (IFG) | |
|---|---|
| People with IFG, in 1,000s | - |
| Age-standardised prevalence of IFG, % | - |
| Impaired Glucose Tolerance (IGT) | |
|---|---|
| People with IGT, in 1,000s | - |
| Age-standardised prevalence of IGT, % | - |
| Mortality attributable to diabetes (20-79 y) | |
|---|---|
| Deaths attributable to diabetes | - |
| Proportion of diabetes-related deaths in people 20-79 y, % | - |
| Hyperglycaemia in pregnancy (HIP) (20-49 y) | |
|---|---|
| Live births affected by HIP | - |
| Prevalence of gestational diabetes mellitus (GDM), % | - |
| Live births affected by other types of diabetes first detected in pregnancy | - |
| Live births affected by other types of diabetes detected prior to pregnancy | - |
| Diabetes-related health expenditure | |
|---|---|
| Total diabetes-related health expenditure, USD million | - |
| Total diabetes-related health expenditure, ID million | - |
| Diabetes-related health expenditure per person, USD | - |
| Diabetes-related health expenditure per person, ID | - |
| Type 1 diabetes estimates in children and adolescents | |
|---|---|
| People with type 1 diabetes (all age groups) | - |
| People with type 1 diabetes (0-19 y) | - |
| Demographics | |
|---|---|
| Total adult population (20-79 y), in 1,000s | 233,013.0 |
| Population of children and adolescents (0-19 y) | - |
